HJNO Jan/Feb 2026

54 JAN / FEB 2026 I  HEALTHCARE JOURNAL OF NEW ORLEANS ONCOLOGY DIAL GUE COLUMN ONCOLOGY SURVIVAL after prostate, bladder, rectal, and other pelvic cancers continues to rise, creat- ing a growing population of male survivors who live many years beyond treatment. This success brings a parallel increase in survi- vorship morbidity, but an emerging nonin- vasive tool shows promise for treating some conditions. Looking Beyond Symptoms to Enhance Survivorship For survivors of prostate, bladder, rectal, and other pelvic cancers, erectile dysfunction, ejaculatory disorders, urinary incontinence, pelvic pain, bowel dysfunction, and disrup- tions in body image and sexual identity re- main common and often persistent. These issues affect relationships, mental health, physical well-being, and adherence to long- term cancer surveillance. As survivorship programs evolve, clini- cal priorities are shifting toward restorative strategies that address underlying biology instead of focusing only on symptom man- agement. Low-intensity extracorporeal shockwave therapy (LiSWT) has emerged as a promising modality in this space because of its regenerative effects and noninvasive nature. Pelvic surgery, radiation, and systemic to distinguish true focused acoustic shock- waves from radial pressure waves, because the two technologies differ significantly in depth of penetration, mechanism of action, and clinical outcomes. True shockwave therapy generates focused acoustic waves that travel at supersonic speed and concentrate energy at a defined depth within tissue. This allows biologic ef- fects such as angiogenesis, stem cell recruit- ment, and nitric oxide pathway activation to occur at relevant depths within the corpora cavernosa. Radial wave devices, often marketed as shockwave therapy, do not generate true shockwaves. Instead, they produce low pres- sure mechanical pulses that disperse super- ficially and lose energy rapidly as they travel through tissue. Radial waves primarily affect the skin and subcutaneous tissue and do not reach penile erectile tissue or deep muscular tissue at therapeutic levels. Because of this, radial devices have not demonstrated the same regenerative outcomes seen with fo- cused acoustic shockwave systems. Understanding the distinction between these modalities is essential for both clini- cians and patients, since efficacy in erec- tile dysfunction and chronic pelvic pain is strongly linked to the delivery of true focused LOW-INTENSITY SHOCKWAVE THERAPY in Male Pelvic Health After Cancer Treatment therapy can disrupt autonomic nerve path- ways, penile and pelvic vasculature, connec- tive tissue structures, and the pelvic floor musculature. Even with improvements in nerve-sparing prostatectomy, most men ex- perience erectile dysfunction during the first postoperative year, andmany never return to baseline function. Radiation therapy further compromises endothelial health, promotes fibrosis, alters smooth muscle signaling, and can worsen chronic pelvic discomfort. These anatomic and functional changes often contribute to anxiety, avoidance of intimacy, and reduced self-confidence, highlighting the need for early intervention and comprehen- sive rehabilitation. LiSWT delivers low-energy acoustic waves to targeted regions. These waves create con- trolled microtrauma that activates cascades of tissue repair, including modulation of in- flammation, increased perfusion, stimulation of angiogenesis, recruitment of stem and pro- genitor cells, and support of nerve regenera- tion. These mechanisms are well validated in musculoskeletal and soft tissue medicine. Ap- plying them to male pelvic health could offer the same biologic principles as well as a po- tential pathway toward tissue recovery rather than temporary symptomatic improvement. When discussing LiSWT, it is important